Amble Health vs Lavender Sky Health vs ShedRx (2026)

On tirzepatide, the order is ShedRx↗ ($289) → Amble Health ($300) → Lavender Sky Health↗ ($352) — gaps of $11 and then $52 a month, a $756 spread across a year between first and last. All-in figures, 10 mg basis, captured 2026-08-09.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

§ Each record, condensed

The three records, one screen

ShedRx: the record, condensed

Start with the load-bearing figure: $289 a month, all-in, is what ShedRx charges for tirzepatide at the 10 mg basis. Pricing steps with the dose here: from $199 at entry to $289 at the 10 mg basis. Multiply the wrong one of those by twelve and your budget is off by $1,080 a year, which is why every ranking on this site uses the larger number.

There is no membership line. $289 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

To place the number: #5 of 17 verified programs, with the floor $74/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $160 a month. A year at this figure: $3,468 monthly-billed.

ShedRx’s semaglutide program bills $249 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. Note the shape: $175 is the number in the marketing, $249 is the number at maintenance. The $74 difference is not a fee or a trick per se — it is dose-tiered pricing doing what dose-tiered pricing does — but it means the advertised figure describes month one, not month twelve.

The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.

Context for that figure: it ranks #13 of 20 in the verified semaglutide index — $116/month above the floor (Oak Longevity, $133) — and sits $100 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $2,988.

Operationally at ShedRx: shipping included; commitment none month-to-month; cancellation 72-hour notice before the next billing cycle; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the ShedRx page · visit ShedRx ↗

Amble Health: the record, condensed

Start with the load-bearing figure: $300 a month, all-in, is what Amble Health charges for tirzepatide at the 10 mg basis. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at Amble Health is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $300 is the whole subscription, which makes Amble Health unusually easy to compare and unusually easy to leave.

To place the number: #9 of 17 verified programs, with the floor $85/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $149 a month. A year at this figure: $3,600 monthly-billed.

Operationally at Amble Health: shipping unknown; commitment unknown; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Amble Health page

Lavender Sky Health: the record, condensed

Lavender Sky Health’s tirzepatide program bills $352 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. The structure is tiered: the advertised entry point is $200, but the maintenance figure — the one a full year is actually billed at — is $352. That $152 gap between the ad and the anniversary is the single most important line in this record.

The all-in figure already contains a compulsory $25 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $327 would be exactly that kind of mirage.

To place the number: #12 of 17 verified programs, with the floor $137/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $97 a month. A year at this figure: $4,224 monthly-billed.

Lavender Sky Health’s semaglutide program bills $174 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. The figure is quoted at maintenance without a separate teaser tier, which keeps the arithmetic honest by default.

Inside that $174 sits a mandatory $25-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $149, and it is not a price anyone can actually pay, because the membership cannot be declined.

Context for that figure: it ranks #6 of 20 in the verified semaglutide index — $41/month above the floor (Oak Longevity, $133) — and sits $175 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $2,088.

Operationally at Lavender Sky Health: shipping included; commitment monthly plan fee recurs; cancellation plan fee recurs until cancelled; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Lavender Sky Health page · visit Lavender Sky Health ↗

§ The three-way read

Prices, gaps, and what sits inside them

ShedRx holds the low ground at $289 with no membership attached. Amble Health follows at $300 (+$11/mo, $132/yr). Lavender Sky Health tops the trio at $352 (+$63/mo over the leader, $756/yr) — note its record’s watch-out below.

The semaglutide picture reshuffles the order: Lavender Sky Health $174 → ShedRx $249 — a reminder that molecule choice and provider choice are separate decisions, priced separately in the semaglutide index.

§ Category winners among the three

Who wins what

Cheapest month-to-month: ShedRx ($289); cheapest 12-month path: ShedRx ($3,468); simplest billing (no membership): ShedRx and Amble Health; dose-flat structure: Amble Health; cheapest semaglutide of the three: Lavender Sky Health ($174).

Every winner above is a computation, not a placement; the pairwise pages carry the full duels: ShedRx vs Amble Health (record · record) · ShedRx vs Lavender Sky Health (record · record) · Amble Health vs Lavender Sky Health (record · record).

§ Structure, three ways

Everything besides the three prices

Memberships: ShedRx none; Amble Health none; Lavender Sky Health $25/mo (inside its figure). Structures: ShedRx step/tiered; Amble Health dose-flat; Lavender Sky Health step/tiered. Pharmacies: ShedRx not named; Amble Health not named; Lavender Sky Health not named. States: ShedRx — not published; Amble Health — not published; Lavender Sky Health — not published. Exit terms: ShedRx — 72-hour notice before the next billing cycle; Amble Health — not published; Lavender Sky Health — plan fee recurs until cancelled.

The census reading: where all three match on an axis, that axis cannot break the tie and the price column rules; where they split — a membership here, an unnamed pharmacy there — the split is usually worth more than a small price gap, because structure is what you live with after month one. Evidence for all three: ShedRx source-verified (2026-08-05); Amble Health third-party reported (2026-08-05); Lavender Sky Health source-verified (2026-08-05).

The trio on semaglutide, across time

3 mo: Lavender Sky Health $522 vs ShedRx $747 6 mo: Lavender Sky Health $1,044 vs ShedRx $1,494 12 mo: Lavender Sky Health $2,088 vs ShedRx $2,988 — monthly-billed totals; prepaid paths where published appear on each provider page.

§ Twelve and twenty-four months

The trio, annualized

ShedRx: $3,468/yr monthly-billed; Amble Health: $3,600/yr monthly-billed; Lavender Sky Health: $4,224/yr monthly-billed. Across two years at monthly billing the first-to-last spread widens to $1,512 — the horizon at which structure (prepaid ladders, flat pricing, membership drag) matters more than the sticker.

The elimination read

A three-way choice is really two eliminations, so run them in order. Eliminate Lavender Sky Health first unless it names its edge: at $352 it carries a $63/month premium over the floor of this trio — $756 a year, about 2.6 extra months of therapy at ShedRx’s rate — and a premium that size must point at a specific line in its record (the services inside its $25/mo membership) or it is decoration. Then interrogate Amble Health’s middle ground: its dose-flat structure removes titration repricing; if that specific thing is on your personal ledger, the $11/month over the floor can be rational — if not, the middle is where budgets go to leak. What survives is ShedRx at $289, which wins by default rather than by argument — exactly how a price index should crown things — subject to the two checks no ranking can run for you: your state at intake, and your prescriber on the medication itself.

The same trio on best published rate: ShedRx $289 → Amble Health $300 → Lavender Sky Health $352 — all three price month-to-month only at capture. Short-horizon totals, monthly-billed: 3 months — ShedRx $867, Amble Health $900, Lavender Sky Health $1,056; 6 months — ShedRx $1,734, Amble Health $1,800, Lavender Sky Health $2,112. 0 of the three publish a prepaid path below their own monthly billing; the twelve- and twenty-four-month table below carries those, labeled.

The record-quality read, scored on the five checkable disclosures this index tracks (maintenance price, named pharmacy, published states, published cancellation terms, source-verified capture): ShedRx 4/5, Amble Health 3/5, Lavender Sky Health 4/5. ShedRx discloses the most and Amble Health the least, and in this market disclosure predicts disclosure — the axis where a program goes quiet is reliably where its checkout surprises live. The three match on every disclosure axis, which is rare and worth noting in their favor collectively. Scores recompute from the public records like everything else here.

Read as a decision: start from ShedRx and make the other two argue upward. Amble Health’s case is its structure; Lavender Sky Health’s case must be worth $756 a year in named features — the honest unit being months of medication (2.6 of them at the floor rate). The pairwise pages above hold each argument in full, and the calculator holds your version of it.